Ebpay生命医药出版社
  • Ebpay生命

    100205

    论文已发表

    提 交 论 文


    注册即可获取Ebpay生命的最新动态

    注 册



    IF 收录期刊



    • 3.3 Breast Cancer (Dove Med Press)
    • 3.4 Clin Epidemiol
    • 2.5 Cancer Manag Res
    • 2.9 Infect Drug Resist
    • 3.5 Clin Interv Aging
    • 4.7 Drug Des Dev Ther
    • 2.7 Int J Chronic Obstr
    • 6.6 Int J Nanomed
    • 2.5 Int J Women's Health
    • 2.5 Neuropsych Dis Treat
    • 2.7 OncoTargets Ther
    • 2.0 Patient Prefer Adher
    • 2.3 Ther Clin Risk Manag
    • 2.5 J Pain Res
    • 2.8 Diabet Metab Synd Ob
    • 2.8 Psychol Res Behav Ma
    • 3.0 Nat Sci Sleep
    • 1.8 Pharmgenomics Pers Med
    • 2.7 Risk Manag Healthc Policy
    • 4.2 J Inflamm Res
    • 2.1 Int J Gen Med
    • 4.2 J Hepatocell Carcinoma
    • 3.7 J Asthma Allergy
    • 1.9 Clin Cosmet Investig Dermatol
    • 2.7 J Multidiscip Healthc



    更多详情 >>





    已发表论文

    荚膜多糖作为高毒力和耐药肺炎克雷伯菌治疗的潜在靶点

     

    Authors Ke Y , Zeng Z, Liu J, Ye C

    Received 29 August 2024

    Accepted for publication 30 January 2025

    Published 3 March 2025 Volume 2025:18 Pages 1253—1262

    DOI http://doi.org/10.2147/IDR.S493635

    Checked for plagiarism Yes

    Review by Single anonymous peer review

    Peer reviewer comments 4

    Editor who approved publication: Dr Sandip Patil

    Yiying Ke,1,2 Zhangrui Zeng,2– 4 Jinbo Liu,2– 4 Caihong Ye2– 4 

    1Department of Clinical Medicine, Southwest Medical University, Luzhou, People’s Republic of China; 2Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People’s Republic of China; 3Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, 646000, People’s Republic of China; 4Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou, 646000, People’s Republic of China

    Correspondence: Caihong Ye, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People’s Republic of China, Tel +86-18281192017, Email yecaihong1997@swmu.edu.cn

    Abstract: Klebsiella pneumoniae is a common cause of antimicrobial-resistant opportunistic infections in hospitalized patients. Hypervirulent Klebsiella pneumoniae (hvKP) acquiring exogenous resistance-encoding and hypervirulence-encoding genetic elements tend to develop both high virulence and resistance. The management of hvKP has also been made more difficult. Capsular polysaccharide (CPS) is the most important virulent factor of hvKP. The high degree of heterogeneity of the CPS and its hindering function adds difficulties in finding a general therapeutic approach. Thus, it is imperative to develop effective ways to target the CPS. The development of CPS-targeting phage treatment has spurred scientific interest. CPS relative vaccines show great potential as therapeutic alternatives to the currently ineffective antibiotics. To find out new ideas for clinical practice, we reviewed the molecular pathogenesis of K. pneumoniae, discussed the biological functions and regulatory factors of CPS. We studied the roles of CPS in virulence, drug resistance, and treatment of K. pneumoniae, and preliminarily investigated the viability of CPS as a target for prevention and therapy of K. pneumoniae infection.

    Keywords: capsular polysaccharide, hypervirulent, Klebsiella pneumoniae, drug-resistance, bacteriophages

    Download Article[PDF]